Search Within

Subhiksha Nandakumar

  1. "2020"
Formats
  1. Journal Article (5)
  2. Meeting Abstract (5)
Groups
  1. Department of Medicine (9)
  2. Sloan Kettering Institute Postdocs (9)
  3. Solid Tumor Oncology Division (9)
  4. GSK Faculty (8)
  5. Genitourinary Oncology Service (8)
  6. Human Oncology and Pathogenesis Program (7)

More Groups

People
  1. Philip Kantoff (8)
  2. Konrad Stopsack (6)
  3. Nikolaus Schultz (6)
  4. Goutam Chakraborty (5)
  5. Ying Mazzu (5)
  6. Bastien Nguyen (4)

More People

Years
  1. 2020 (10)
Publications
  1. Journal of Clinical Oncology (3)
  2. Cancer Research (2)
  3. Clinical Cancer Research (2)
  4. European Urology (1)
  5. Gastroenterology (1)
  6. Molecular Oncology (1)
Publishers
  1. American Association for Cancer Research (4)
  2. American Society of Clinical Oncology (3)
  3. Elsevier Inc. (1)
  4. Elsevier Science, Inc. (1)
  5. FEBS Press (1)

Results (10)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Integrative analysis of clinical and genomic information identifies predictive markers of metastatic risk
    Meeting Abstract

    Fong, C. J.; Sanchez-Vega, F.; Ngyuen, B.; Luthra, A.; Nandakumar, S.; Walch, H.; Chatila, W.; Rajanna, A.; Zehir, A.; Berger, M.; more...
    Cancer Research (2020)

    Fulltext@MSK | Save
  • CDK12 alterations define a distinct molecular subtype of prostate cancers with unique genomic and clinical characteristics
    Meeting Abstract

    Nguyen, B.; Mota, J. M.; Nandakumar, S.; Stopsack, K. H.; Weg, E.; Rathkopf, D.; Morris, M. J.; Scher, H.; Kantoff, P. W.; Gopalan, A.; more...
    Cancer Research (2020)

    Fulltext@MSK | Save
  • Specific mutations in APC, but not alterations in DNA damage response, associate with outcomes of patients with metastatic colorectal cancer
    Journal Article

    Mondaca, S.; Walch, H.; Nandakumar, S.; Chatila, W. K.; Schultz, N.; Yaeger, R.
    Gastroenterology (2020)

    Fulltext@MSK | Save
  • Pan-cancer analysis of CDK12 alterations identifies a subset of prostate cancers with distinct genomic and clinical characteristics
    Journal Article

    Nguyen, B.; Mota, J. M.; Nandakumar, S.; Stopsack, K. H.; Weg, E.; Rathkopf, D.; Morris, M. J.; Scher, H. I.; Kantoff, P. W.; Gopalan, A.; more...
    European Urology (2020)

    Fulltext@MSK | Save
  • Ribonucleotide reductase small subunit M2 is a master driver of aggressive prostate cancer
    Journal Article

    Mazzu, Y. Z.; Armenia, J.; Nandakumar, S.; Chakraborty, G.; Yoshikawa, Y.; Jehane, L. E.; Lee, G. S. M.; Atiq, M.; Khan, N.; Schultz, N.; more...
    Molecular Oncology (2020)

    Fulltext@MSK | Save
  • Oncogenic genomic alterations, clinical phenotypes, and outcomes in metastatic castration-sensitive prostate cancer
    Journal Article

    Stopsack, K. H.; Nandakumar, S.; Wibmer, A. G.; Haywood, S.; Weg, E. S.; Barnett, E. S.; Kim, C. J.; Carbone, E. A.; Vasselman, S. E.; Nguyen, B.; more...
    Clinical Cancer Research (2020)

    Fulltext@MSK | Save
  • The impact of the expression of the transcription factor MYBL2 on outcomes of patients with localized and advanced prostate cancer
    Meeting Abstract

    Yoshikawa, Y.; Wang, X. V.; Chen, Y. H.; Mazzu, Y. Z.; Chakraborty, G.; Jehane, L. E.; Rajanala, S. H.; Hirani, R.; Nandakumar, S.; Stopsack, K. H.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Fraction genome altered (FGA) to regulate both cell autonomous and non-cell autonomous functions in prostate cancer and its effect on prostate cancer aggressiveness
    Meeting Abstract

    Chakraborty, G.; Ghosh, A.; Nandakumar, S.; Armenia, J.; Mazzu, Y. Z.; Atiq, M. O.; Lee, G. S. M.; Mucci, L. A.; Merghoub, T.; Wolchok, J. D.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Checkpoint kinase inhibition in prostate cancer cells resistant to poly ADP-ribose polymerase inhibitors
    Meeting Abstract

    Atiq, M. O.; Chakraborty, G.; Nandakumar, S.; Mazzu, Y. Z.; Stopsack, K. H.; Yoshikawa, Y.; Lee, G. S. M.; Kantoff, P. W.
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Significance of BRCA2 and RB1 co-loss in aggressive prostate cancer progression
    Journal Article

    Chakraborty, G.; Armenia, J.; Mazzu, Y. Z.; Nandakumar, S.; Stopsack, K. H.; Atiq, M. O.; Komura, K.; Jehane, L.; Hirani, R.; Chadalavada, K.; more...
    Clinical Cancer Research (2020)

    Fulltext@MSK | Save